Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-056093

General Counsel and Secretary gave up 4,741 shares (to pay taxes)

  • General Counsel and Secretary acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
KASINGER JAMES R. General Counsel and Secretary 2021-09-10 Option exercise +10,000 33,911 D
KASINGER JAMES R. General Counsel and Secretary 2021-09-13 Shares withheld for taxes −4,741 $117.86 $558,774 29,170 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2021-09-10 Returned to the company · Restricted Stock Units −10,000 0 D
Loading xslF345X03/doc4.xml…